Deciphera Pharmaceuticals, Inc.

NASDAQ:DCPH

25.59 (USD) • At close June 10, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Omzet 44.99948.29443.31338.30433.44536.34535.97432.49429.22324.19923.2223.57325.15619.48615.4497.090.062002500000000000
Kosten van de omzet 3.6851.7851.2860.1730.4883.2453.3441.7990.3820.5180.9171.2750.2220.1270.090.008000000000000000
Brutowinst 41.31446.50942.02738.13132.95733.132.6330.69528.84123.68122.30322.29824.93419.35915.3597.0820.062002500000000000
Brutowinstmarge 0.9180.9630.970.9950.9850.9110.9070.9450.9870.9790.9610.9460.9910.9930.9940.999100100000000000
Onderzoek- en ontwikkelingskosten 57.38458.59962.46358.29654.76548.06647.48544.85847.41274.93266.44459.98455.68152.28849.21346.08151.38846.63640.37434.81135.78927.35620.6317.97616.92515.6589.7518.4465.6596.5374.717
Algemene en administratieve kosten 0000000000000000044.37917.97913.16413.2366.4745.2594.4535.0264.682.432.2442.0671.9971.35
Verkoop- en marketingkosten 00000000000000000-20.6420000000000000
Verkoop-, algemene en administratieve kosten 32.77739.14833.25232.6131.44932.19530.02629.62528.32137.15135.52732.82830.74730.0730.14329.93323.93623.73717.97913.16413.2366.4745.2594.4535.0264.682.432.2442.0671.9971.35
Overige kosten 000000000000000000000000000.166000.002-0.006
Bedrijfskosten 90.16197.74795.71590.90686.21480.26177.51174.48375.733112.083101.97192.81286.42882.35879.35676.01475.32470.37358.35347.97549.02533.8325.88922.42921.95120.33812.18110.697.7268.5346.067
Bedrijfsresultaat -48.847-51.238-53.688-52.775-53.257-47.161-44.881-43.788-47.675-88.401-79.668-70.514-61.494-62.999-63.997-68.932-75.262-70.373-58.353-22.975-49.025-33.83-25.889-22.429-21.951-20.338-12.181-10.69-7.726-8.534-6.067
Bedrijfsresultaat ratio -1.086-1.061-1.24-1.378-1.592-1.298-1.248-1.348-1.631-3.653-3.431-2.991-2.445-3.233-4.142-9.722-1,213.90300-0.91900000000000
Totaal overige inkomsten en kosten netto 3.7644.4794.1074.2133.6481.9261.8380.7270.783-0.006-0.170.0810.1960.2590.2961.6912.4553.1572.1571.5151.6411.5311.4540.7390.5210.4260.1660.0650.0170.002-0.006
Inkomen voor belasting -45.083-46.759-49.581-48.562-49.609-45.235-43.043-43.061-46.892-88.396-79.838-70.433-61.298-62.74-63.701-67.241-72.807-67.216-56.196-21.46-47.384-32.299-24.435-21.69-21.43-19.912-12.038-10.625-7.709-8.557-6.099
Inkomen voor belasting ratio -1.002-0.968-1.145-1.268-1.483-1.245-1.197-1.325-1.605-3.653-3.438-2.988-2.437-3.22-4.123-9.484-1,174.30600-0.85800000000000
Belastingkosten 00.431-0.4650-0.6080.7-3.676-1.454-0.7830.0060000.2590.2961.6912.4552.7242.1741.541.6541.4521.4750.760.5430.4490.150.0890.0420.0270.02
Nettowinst -45.083-47.19-49.581-48.562-49.609-45.935-39.367-41.607-46.109-88.395-79.838-70.433-61.298-62.74-63.701-67.241-72.807-67.216-56.196-21.46-47.384-32.299-24.435-21.69-21.43-19.912-12.038-10.625-7.709-8.557-6.099
Nettowinstmarge -1.002-0.977-1.145-1.268-1.483-1.264-1.094-1.28-1.578-3.653-3.438-2.988-2.437-3.22-4.123-9.484-1,174.30600-0.85800000000000
WPA (Winst Per Aandeel) -0.52-0.54-0.58-0.57-0.6-0.6-0.5-0.58-0.79-1.51-1.37-1.21-1.06-1.11-1.13-1.2-1.36-1.31-1.28-0.56-1.25-0.86-0.65-0.65-0.66-0.61-5.85-0.35-0.37-0.41-0.29
Verwaterde WPA -0.52-0.54-0.58-0.57-0.6-0.6-0.5-0.58-0.79-1.51-1.37-1.21-1.06-1.11-1.13-1.2-1.36-1.31-1.28-0.56-1.25-0.86-0.65-0.65-0.66-0.61-5.85-0.35-0.37-0.41-0.29
EBITDA -47.25-50.782-53.688-52.204-53.257-47.161-44.139-42.968-46.892-88.402-78.909-69.771-60.762-62.045-63.035-66.757-72.347-67.204-56.01-21.323-47.267-32.279-24.326-21.595-21.352-19.84-12.015-10.57-7.653-8.502-6.051
EBITDA ratio -1.05-1.052-1.24-1.363-1.592-1.298-1.227-1.322-1.605-3.653-3.398-2.96-2.415-3.184-4.08-9.416-1,166.88700-0.85300000000000